Vanguard Group’s Ensysce Biosciences ENSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,212
| Closed | -$4.36K | – | 4303 |
|
|
2024
Q3 | $4.36K | Hold |
1,212
| – | – | ﹤0.01% | 4340 |
|
|
2024
Q2 | $9.21K | Hold |
1,212
| – | – | ﹤0.01% | 4393 |
|
|
2024
Q1 | $14.4K | Hold |
1,212
| – | – | ﹤0.01% | 4411 |
|
|
2023
Q4 | $19.3K | Buy |
1,212
+184
| +18% | +$2.93K | ﹤0.01% | 4448 |
|
|
2023
Q3 | $21.3K | Hold |
1,028
| – | – | ﹤0.01% | 4493 |
|
|
2023
Q2 | $27.8K | Buy |
+1,028
| New | +$27.8K | ﹤0.01% | 4502 |
|
|
2022
Q4 | – | Sell |
-88
| Closed | -$68K | – | 4536 |
|
|
2022
Q3 | $68K | Buy |
88
+54
| +159% | +$41.7K | ﹤0.01% | 4520 |
|
|
2022
Q2 | $106K | Hold |
34
| – | – | ﹤0.01% | 4541 |
|
|
2022
Q1 | $140K | Sell |
34
-50
| -60% | -$206K | ﹤0.01% | 4576 |
|
|
2021
Q4 | $1.42M | Buy |
+84
| New | +$1.42M | ﹤0.01% | 4161 |
|